Page last updated: 2024-08-22

cyclic cmp and cangrelor

cyclic cmp has been researched along with cangrelor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cattaneo, M; Lecchi, A	1

Other Studies

1 other study(ies) available for cyclic cmp and cangrelor

Article	Year
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin. Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Blood Platelets; Cyclic AMP; Cyclic CMP; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Thrombin	2007

Article

Year

Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.

Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:3

Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Blood Platelets; Cyclic AMP; Cyclic CMP; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Thrombin

2007